Home > Official notices > Statutory Committee inquiries  |  Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7456 p721-722
16 June 2007


Statutory Committee inquiries

The Statutory Committee will meet at the Royal Pharmaceutical Society of Great Britain, 1 Lambeth High Street, London SE1, at 9.30am on Monday 18 June and Tuesday 19 June 2007 to hear the following matters:

1. The committee will hear the new inquiry into the case of Ian Anthony McAsey (registration number 85173), which alleges that the authorisation and subsequent receiving of payments of £212 and £336, which he was not entitled to, while working as a locum pharmacist and the subsequent failure to report or repay the amount, may amount to misconduct.

2. The committee will deliver the determination of the inquiry into the case of Sheila Elizabeth Coventry (registration number 81492) who on 13 December 2005 at Edinburgh sheriff court was convicted of assault to injury.

3. The committee will deliver the determination of the inquiry into a complaint by the Council of the Society against Neil Hutchinson (registration number 79982) and Carol Janette Hutchinson (registration number 79981), which alleges, in relation to Mr Hutchinson, that a number of dispensing errors; the supply of a Controlled Drug, namely 30 Concerta X tablets, against a prescription for 14 such tablets; a failure to comply with the labelling regulations; a breach of Regulation 19 of the Misuse of Drugs Regulations 2001 relating to record-keeping; a failure to supply a patient with his medication and the pharmacy’s failure to deal with the subsequent complaint appropriately; the supply of medication to a patient without reference to a prescription or a copy prescription and without checking with the prescriber; an over-supply of candesartan tablets and a failure to label this supply accurately; a failure to keep a verifiable audit trail of the supply of prescription only medication; the supply of medication to a patient by reference only to previously incorrectly supplied medication and the labelling from an old monitored dosage system pack; a failure to act in the best interests of a patient; a failure to deal with a patient’s mother in a professional and courteous manner; a failure as superintendent pharmacist to have in place a system to identify each pharmacist responsible for particular supply; a failure to heed the advice of the Society; a failure to have in place adequate procedures for dispensing in monitored dosage systems; the pharmacy’s inadequate procedures for dealing with errors and complaints; an unacceptably dirty and untidy pharmacy; a failure to assess or remove date-expired chemicals and/or medication; the presence at the pharmacy of patient returned medication, including prescription only medication, on a stairway to which customers had access, in the stockroom and in the office; and the dispensing of owings without reference to the relevant prescription, may amount to misconduct. In relation to Mrs Hutchinson, the Society’s council alleges that the supply of a Controlled Drug, namely 30 Concerta X tablets, against a prescription for 14 such tablets; a breach of Regulation 19 of the Misuse of Drugs Regulations 2001 relating to record-keeping; the pharmacy’s failure to deal appropriately with a complaint; a failure of the pharmacy to keep a verifiable audit trail of the supply of prescription only medication; the failure of the pharmacy to have in place a system to identify each pharmacist responsible for a particular supply; a failure to heed the advice of the Society; the supply of medication to a patient using only previously incorrect medication and labelling from an old monitored dosage system pack; the pharmacy’s failure to have in place adequate procedures governing dispensing in monitored dosage systems; the pharmacy’s inadequate procedures for dealing with errors and complaints; an unacceptably dirty and untidy pharmacy; a failure to assess or remove date-expired chemicals and/or medication; the presence at the pharmacy of patient returned medication, including prescription only medication, on a stairway to which customers had access, in the stockroom and in the office; and a failure to record maximum and minimum refrigerator temperatures daily, may amount to misconduct.

David Gomez
Secretary to the Statutory Committee

Back to Top


©The Pharmaceutical Journal